The Psychedelic Medicine Association’s mission is to educate healthcare professionals on psychedelic therapies as a means to increase patients’ ability to access these medicines when they are appropriate and available.
However, having knowledgeable healthcare providers is only one of many factors that impact accessibility. Additional factors include having enough therapists trained in psychedelic-assisted psychotherapy, having safe and legal access to the medicines, and having cost-effective ways to administer the medicines so that lack of financial resources doesn’t prevent patients from accessing them.
To discuss ways to increase accessibility in some of these areas, we have invited on guests who are currently using different means to help patients get the therapies they need.
They’ll help educate us on:
- How nonprofits can play an important role in helping patients access psychedelic therapeutics
- How research organizations and drug development companies can foster accessibility
- Ways that you, as clinicians, can help your patients access therapies that are currently legal and available
As always, there will be ample time for audience Q & A, so you’ll get to interact with the panelists directly!
So please join us for this live panel discussion on Thursday, January 26th at 5 pm Pacific, 8 pm Eastern. This is exclusively for members of the Psychedelic Medicine Association, so if you have not yet registered, please do so here. A link to the recording will be available afterward if you cannot make it to the live event.
Hope to see you all on the 26th!


